Chapel Hill, NC, United States of America

John R Plachetka

This inventor holds 30 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Pozen Inc., Horizon Pharma USA, Inc., Genus Lifesciences Inc.. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John R Plachetka. Retrieved from https://idiyas.com/inventor/john-r-plachetka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 11)

% Patents Active = 46.7

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 1.3

ph-index = 28

Forward Citations = 3,598(Granted Patents)

Company Filing History:

Horizon Pharma USA, Inc.

patents

1 out of 23

Genus Lifesciences Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

NSAIDs

Migraine Treatment

Drug Delivery

Dihydroergotamine

5-HT Agonists

Dosage Forms

Combination Therapies

Ulcer Prevention

Headache Treatment

Omeprazole

Acetylsalicylic Acid

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10603283 - Compositions and methods for delivery of omeprazole plus acetylsalicylic acid (2020-03-31),

2. 9987231 - Compositions and methods for delivery of omeprazole plus acetylsalicylic acid (2018-06-05),

3. 9801827 - Dosage forms for administering combinations of drugs (2017-10-31),

4. 9801824 - Method for delivering a pharmaceutical composition to patient in need thereof (2017-10-31),

5. 9707181 - Pharmaceutical compositions for the coordinated delivery of NSAIDs (2017-07-18),

6. 9539214 - Compositions and methods for delivery of omeprazole plus acetylsalicylic acid (2017-01-10),

7. 9393208 - Method for delivering a pharmaceutical composition to patient in need thereof (2016-07-19),

8. 9364439 - Pharmaceutical compositions for the coordinated delivery of NSAIDs (2016-06-14),

9. 9345695 - Pharmaceutical compositions for the coordinated delivery of NSAIDs (2016-05-24),

10. 9265732 - Dosage forms for administering combinations of drugs (2016-02-23),

11. 9220698 - Method for delivering a pharmaceutical composition to patient in need thereof (2015-12-29),

12. 9198888 - Pharmaceutical compositions for the coordinated delivery of NSAIDs (2015-12-01),

13. 9161920 - Pharmaceutical compositions for the coordinated delivery of NSAIDs (2015-10-20),

14. 8945621 - Method for treating a patient at risk for developing an NSAID-associated ulcer (2015-02-03),

15. 8865190 - Pharmaceutical compositions for the coordinated delivery of NSAIDs (2014-10-21),

Title: Innovations of John R. Plachetka in Pharmaceutical Delivery Systems

Introduction

John R. Plachetka, based in Chapel Hill, NC, is a notable inventor with a remarkable portfolio of 30 patents. His work primarily focuses on pharmaceutical compositions and methods of delivery, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents, Plachetka has contributed significantly to the formulation of compositions and methods for the delivery of omeprazole plus acetylsalicylic acid. His patent outlines a method for delivering a pharmaceutical composition to patients in need, specifically through administering a unit dose that includes both acetylsalicylic acid and omeprazole or their pharmaceutically acceptable salts. This innovation aims to enhance the efficacy and safety of treatments involving these compounds.

Career Highlights

Throughout his career, Plachetka has worked with notable companies in the pharmaceutical industry, including Pozen Inc. and Horizon Pharma USA, Inc. His extensive experience has equipped him with the expertise necessary to develop impactful medical solutions that address patient needs.

Collaborations

In the course of his career, Plachetka has collaborated with talented professionals such as Donna Gilbert and Brian Ault. These partnerships have fostered an environment of innovation, leading to the successful development of his patented technologies.

Conclusion

John R. Plachetka stands as a significant figure in the realm of pharmaceutical innovations. His extensive patent portfolio not only reflects his expertise but also highlights his dedication to improving healthcare through advanced drug delivery methods. As he continues to develop new solutions, Plachetka's contributions are likely to influence the future of pharmaceutical formulations positively.

Profile summary based on public USPTO records.